Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population

BackgroundNon-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined th...

Full description

Bibliographic Details
Main Authors: Yaqin Wang, Ting Yuan, Shuwen Deng, Xiaoling Zhu, Yuling Deng, Xuelian Liu, Lei Liu, Changfa Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Nutrition
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fnut.2023.1104859/full
_version_ 1797680847307931648
author Yaqin Wang
Ting Yuan
Shuwen Deng
Xiaoling Zhu
Yuling Deng
Xuelian Liu
Lei Liu
Changfa Wang
author_facet Yaqin Wang
Ting Yuan
Shuwen Deng
Xiaoling Zhu
Yuling Deng
Xuelian Liu
Lei Liu
Changfa Wang
author_sort Yaqin Wang
collection DOAJ
description BackgroundNon-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined the relationship between body mass index (BMI), the metabolically healthy status, and subclinical atherosclerosis in the NAFLD population.MethodsData from asymptomatic NAFLD subjects who participated in a routine health check-up examination were collected. Participants were stratified by BMI (cutoff values: 24.0–27.9 kg/m2 for overweight and ≥28.0 kg/m2 for obesity) and metabolic status, which was defined by Adult Treatment Panel III criteria. Subclinical atherosclerosis was evaluated by brachial-ankle pulse wave velocity (baPWV) in 27,738 participants and by carotid plaque in 14,323 participants.ResultsWithin each BMI strata, metabolically unhealthy subjects had a significantly higher prevalence of subclinical atherosclerosis than metabolically healthy subjects, whereas fewer differences were observed across subjects within the same metabolic category. When BMI and metabolic status were assessed together, a metabolically unhealthy status was the main contributor to the association of clinical phenotypes with the subclinical atherosclerosis burden (all p < 0.001). When BMI and metabolic abnormalities were assessed separately, the incidence of subclinical disease did not increase across BMI categories; however, it increased with an increase in the number of metabolic abnormalities (0, 1, 2 and ≥3).ConclusionA metabolically healthy status in NAFLD patients was closely correlated with subclinical atherosclerosis, beyond that of the BMI-based obesity phenotype. The application of metabolic phenotyping strategies could enable more precise classification in evaluating cardiovascular risk in NAFLD.
first_indexed 2024-03-11T23:36:14Z
format Article
id doaj.art-b67380c2160e460fb2fc02cdae168aac
institution Directory Open Access Journal
issn 2296-861X
language English
last_indexed 2024-03-11T23:36:14Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Nutrition
spelling doaj.art-b67380c2160e460fb2fc02cdae168aac2023-09-20T02:51:29ZengFrontiers Media S.A.Frontiers in Nutrition2296-861X2023-09-011010.3389/fnut.2023.11048591104859Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease populationYaqin Wang0Ting Yuan1Shuwen Deng2Xiaoling Zhu3Yuling Deng4Xuelian Liu5Lei Liu6Changfa Wang7Health Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaHealth Management Center, The Third Xiangya Hospital, Central South University, Changsha, ChinaDepartment of General Surgery, The Third Xiangya Hospital, Central South University, Changsha, ChinaBackgroundNon-alcoholic fatty liver disease (NAFLD), especially lean NAFLD is associated with an increased risk of atherosclerotic cardiovascular disease (CVD). It is not currently known which clinical phenotypes of NAFLD contribute most to individual subclinical atherosclerosis risk. We examined the relationship between body mass index (BMI), the metabolically healthy status, and subclinical atherosclerosis in the NAFLD population.MethodsData from asymptomatic NAFLD subjects who participated in a routine health check-up examination were collected. Participants were stratified by BMI (cutoff values: 24.0–27.9 kg/m2 for overweight and ≥28.0 kg/m2 for obesity) and metabolic status, which was defined by Adult Treatment Panel III criteria. Subclinical atherosclerosis was evaluated by brachial-ankle pulse wave velocity (baPWV) in 27,738 participants and by carotid plaque in 14,323 participants.ResultsWithin each BMI strata, metabolically unhealthy subjects had a significantly higher prevalence of subclinical atherosclerosis than metabolically healthy subjects, whereas fewer differences were observed across subjects within the same metabolic category. When BMI and metabolic status were assessed together, a metabolically unhealthy status was the main contributor to the association of clinical phenotypes with the subclinical atherosclerosis burden (all p < 0.001). When BMI and metabolic abnormalities were assessed separately, the incidence of subclinical disease did not increase across BMI categories; however, it increased with an increase in the number of metabolic abnormalities (0, 1, 2 and ≥3).ConclusionA metabolically healthy status in NAFLD patients was closely correlated with subclinical atherosclerosis, beyond that of the BMI-based obesity phenotype. The application of metabolic phenotyping strategies could enable more precise classification in evaluating cardiovascular risk in NAFLD.https://www.frontiersin.org/articles/10.3389/fnut.2023.1104859/fullcross-sectional studymetabolic statusobesity phenotypesubclinical atherosclerosisnon-alcoholic fatty liver disease
spellingShingle Yaqin Wang
Ting Yuan
Shuwen Deng
Xiaoling Zhu
Yuling Deng
Xuelian Liu
Lei Liu
Changfa Wang
Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
Frontiers in Nutrition
cross-sectional study
metabolic status
obesity phenotype
subclinical atherosclerosis
non-alcoholic fatty liver disease
title Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
title_full Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
title_fullStr Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
title_full_unstemmed Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
title_short Metabolic health phenotype better predicts subclinical atherosclerosis than body mass index-based obesity phenotype in the non-alcoholic fatty liver disease population
title_sort metabolic health phenotype better predicts subclinical atherosclerosis than body mass index based obesity phenotype in the non alcoholic fatty liver disease population
topic cross-sectional study
metabolic status
obesity phenotype
subclinical atherosclerosis
non-alcoholic fatty liver disease
url https://www.frontiersin.org/articles/10.3389/fnut.2023.1104859/full
work_keys_str_mv AT yaqinwang metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT tingyuan metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT shuwendeng metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT xiaolingzhu metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT yulingdeng metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT xuelianliu metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT leiliu metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation
AT changfawang metabolichealthphenotypebetterpredictssubclinicalatherosclerosisthanbodymassindexbasedobesityphenotypeinthenonalcoholicfattyliverdiseasepopulation